Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer

OBJECTIVE: In this study, we evaluated the toxicity and clinical efficacy of nivolumab, a programmed cell death protein 1 (PD-1) inhibitor, on patients with platinum resistant ovarian cancer. METHODS: Every second week, 18 patients with platinum resistance ovarian cancer received nivolumab until dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gynecol Oncol
Main Authors: Normann, Marius C., Türzer, Martin, Diep, Lien My, Oldenburg, Jan, Gajdzik, Beata, Solheim, Olesya, Rud, Erik
Formato: Artigo
Idioma:Inglês
Publicado em: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543107/
https://ncbi.nlm.nih.gov/pubmed/31074244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2019.30.e56
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados